CVS Health Corporation ($CVS) Stock Forecast: Up 5.1% Today

What is CVS Health Corporation?

CVS Health is a leading healthcare company operating pharmacies and providing health services. The overall market sentiment today was bullish.

Why is CVS Health Corporation going up?

CVS stock is up 5.1% on Feb 13, 2025 18:50

• Upbeat earnings were reported by CVS Health for the fourth quarter, surpassing sales expectations and leading to a positive outlook from analysts.
• The company foresees 10% earnings growth for 2025, primarily driven by Aetna's recovery, which further bolstered investor confidence.
• The positive trend in earnings and growth outlook in the healthcare sector, as exemplified by companies like Coca-Cola, Pepsi, and Walgreens Boots Alliance, likely contributed to CVS's strong bullish movement today.
• Analyst upgrades and a favorable earnings outlook for the healthcare industry as a whole may have also influenced the upward movement of CVS's stock price.

CVS Price Chart

CVS Technical Analysis

CVS News

These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings - CVS Health ( NYSE:CVS )

CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday. The company posted fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

https://www.benzinga.com/25/02/43692947/these-analysts-boost-their-forecasts-on-cvs-health-following-upbeat-earnings

This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - CVS Health ( NYSE:CVS ) , AstraZeneca ( NASDAQ:AZN )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

https://www.benzinga.com/25/02/43690198/this-astrazeneca-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday

Zacks Earnings Trends Highlights: Coca-Cola, CVS, Pepsi and Walgreens Boots Alliance

Coca-Cola, CVS, Pepsi and Walgreens Boots Alliance have been highlighted in this Earnings Trends article.

https://www.zacks.com/stock/news/2415044/zacks-earnings-trends-highlights-coca-cola-cvs-pepsi-and-walgreens-boots-alliance

CVS Health Forecasts 10% Earnings Growth For 2025, Citing Aetna's 'Meaningful Recovery' - CVS Health ( NYSE:CVS ) , SPDR S&P 500 ( ARCA:SPY )

Full-year 2025 guidance for adjusted EPS stood in the range of $5.75 to $6 per share. CVS also guided for $6.5 billion in cash flow from operations for 2025. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights. CVS Health Corp.

https://www.benzinga.com/news/earnings/25/02/43684201/cvs-health-forecasts-10-earnings-growth-for-2025-citing-aetnas-meaningful-recovery

Breaking Down the Current Earnings Outlook

We can safely say that it has been a good reporting cycle, with the growth pace showing a notable accelerating trend and companies comfortably beating consensus estimates. But what about the coming periods?

https://www.zacks.com/commentary/2415003/breaking-down-the-current-earnings-outlook

Trending Today

Sonic (prev. FTM) ($S) Crypto Forecast: Down 5.5% Today

Memecoin ($MEME) Crypto Forecast: Up 7.7% Today

Maker ($MKR) Crypto Forecast: Up 6.0% Today

Ethena ($ENA) Crypto Forecast: Down 5.6% Today

Movement ($MOVE) Crypto Forecast: Up 5.1% Today

MANTRA ($OM) Crypto Forecast: Up 5.3% Today

Ethereum ($ETH) Crypto Forecast: Up 5.0% Today

Toncoin ($TON) Crypto Forecast: Up 5.0% Today

Pepe ($PEPE) Crypto Forecast: Up 6.4% Today

dogwifhat ($WIF) Crypto Forecast: Up 9.8% Today

CVS Health Corporation Price History

18.10.2024 - CVS Stock was up 5.1%

• Third Point Hedge Fund's purchase of Tesla and divestment from Micron may have signaled a shift in investor sentiment towards tech and healthcare stocks.
• The bullish movement of CVS could be attributed to investor optimism despite the uncertainties highlighted in the assessment regarding the company's outlook for 2024.
• The overall positive market sentiment towards healthcare stocks may have also contributed to CVS's strong performance today.

06.10.2024 - CVS Stock was up 11.6%

• Exceeded earnings and revenue expectations for the third quarter.
• The new CEO's cautious approach and decision not to provide guidance initially caused uncertainty among investors.
• However, investors are optimistic about CVS Health's ability to overcome recent challenges.
• Analysts and investors closely monitored key metrics and estimates, contributing to the positive market sentiment surrounding the stock.

06.10.2024 - CVS Stock was up 11.2%

• Today, CVS stock saw a strong bullish movement subsequent to its mixed Q3 earnings, where it exceeded revenue estimates and reported positive earnings surprises.
• Despite a $1.2 billion restructuring charge, CVS experienced a 6.3% growth in total revenues driven by key segments like Health Care Benefits and Pharmacy & Consumer Wellness.
• Analysts on Wall Street are positive about CVS Health, recommending adding the stock to portfolios and showing confidence in the company's future.
• Although CVS chose not to provide guidance due to expected high medical costs, this decision initially sparked concerns but was overshadowed by the positive earnings and revenue surprises.

06.10.2024 - CVS Stock was up 11.6%

• CVS stock saw a significant bullish trend post its Q3 earnings release, which exceeded expectations and displayed growth in key sectors such as Health Services and Pharmacy & Consumer Wellness.
• Despite facing a $1.2 billion restructuring charge, CVS recorded a 6.3% increase in overall revenue, primarily propelled by strong performances in Health Care Benefits and Pharmacy & Consumer Wellness divisions.
• Analysts on Wall Street hold an optimistic view on CVS Health, recommending to include the stock in one's portfolio, reflecting confidence in the company's future outlook.
• Opting to refrain from giving guidance due to anticipated ongoing pressure from heightened medical costs may have initially caused uncertainty, but the positive earnings and revenue results likely reassured investors, driving the bullish market sentiment.

13.11.2024 - CVS Stock was down 5.2%

• The technical analysis suggests that CVS stock is breaking important support levels, indicating a potential formation of a new downtrend, which has likely contributed to the bearish movement.
• The bipartisan lawmakers' aim to break up health care giants, including CVS Health, with new legislation might have added uncertainty and negative sentiment around the stock, leading to the downward pressure.
• The concerns raised about CVS' high utilization and medical benefit ratio impacting future profits could have further fueled investor apprehensions, contributing to the bearish market movement.
• Despite some optimism from Wall Street analysts recommending CVS as a buy, the overall negative sentiment surrounding the company's future profitability and regulatory challenges seems to have overshadowed the positive outlook, driving the stock lower.

11.11.2024 - CVS Stock was down 5.3%

• The options market sentiment towards CVS Health has been bullish, but this may not have translated into a positive stock movement today.
• The high utilization of medical services impacting CVS Health's profits could be a significant factor contributing to the bearish movement.
• Despite optimistic recommendations from Wall Street analysts, the stock experienced a decline, possibly due to concerns about the company's future profits.
• The stock's performance since the last earnings report, where it decreased by 0.4%, might have influenced today's bearish movement as investors reassess the company's financial outlook.

18.09.2024 - CVS Stock was down 5.6%

• The company revised its third-quarter outlook, causing a significant drop in its stock price.
• The appointment of David Joyner as the new CEO during a financially challenging period for the company may have increased investor concerns, contributing to the negative market trend.
• Despite this, there is noteworthy options activity showing bullish behavior from large investors, implying a possible divergence between short-term and long-term market sentiments for CVS Health.

17.11.2024 - CVS Stock was down 5.7%

• The stock price of CVS Health (CVS) decreased by -0.42% today, indicating a bearish movement in the market.
• Technical analysis suggests that CVS may be breaking important support levels, potentially signaling the formation of a new downtrend.
• Discussions among bipartisan lawmakers regarding the breakup of health care giants, including CVS, with new legislation could have influenced the bearish sentiment surrounding the stock.
• Despite the bullish stance taken by some deep-pocketed investors towards CVS Health, the overall market movement today favored a bearish outlook, possibly driven by regulatory concerns related to the industry.

12.01.2025 - CVS Stock was up 17.4%

• CVS stock saw significant bullish movement recently.
• The uptrend followed an impressive Q4 earnings performance, surpassing both revenue and earnings projections.
• Bullish bets from market whales on CVS options added to the positive market sentiment.
• Investor confidence in CVS Health's growth outlook was strengthened by the appointment of a new CEO and positive expectations for FY25.

13.01.2025 - CVS Stock was up 5.1%

• Upbeat earnings were reported by CVS Health for the fourth quarter, surpassing sales expectations and leading to a positive outlook from analysts.
• The company foresees 10% earnings growth for 2025, primarily driven by Aetna's recovery, which further bolstered investor confidence.
• The positive trend in earnings and growth outlook in the healthcare sector, as exemplified by companies like Coca-Cola, Pepsi, and Walgreens Boots Alliance, likely contributed to CVS's strong bullish movement today.
• Analyst upgrades and a favorable earnings outlook for the healthcare industry as a whole may have also influenced the upward movement of CVS's stock price.

12.01.2025 - CVS Stock was up 16.9%

• CVS stock saw a substantial increase today after the release of its Q4 earnings report.
• Earnings and revenue surpassed expectations, with margins improving and same-store prescription volume showing significant growth.
• Despite a slight miss in adjusted EPS, the stock surged by 10% due to a positive FY25 outlook and better-than-expected earnings and revenue results.
• Investors reacted favorably to the company's performance, focusing on the growth in Pharmacy & Consumer Wellness sales while overlooking challenges in the Health Services segment.

12.01.2025 - CVS Stock was up 13.3%

• Strong Q4 earnings were reported by CVS Health, with revenue surpassing expectations and a 5.9% increase in same-store prescription volume, leading to a positive stock movement.
• Despite a decline in Health Services revenue, the growth in Pharmacy & Consumer Wellness sales boosted overall performance.
• The appointment of new CEO David Joyner resulted in a 10% increase in CVS shares, indicating investor confidence.
• Despite concerns raised by analysts about cost trend pressures before earnings, CVS stock saw an upward trend due to a positive FY25 outlook and strong performance in key segments.